Interferon beta-1b

Therapeutic indications

Interferon beta-1b is indicated for:

Multiple sclerosis

Population group: only adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Interferon beta-1b is indicated for the treatment of:

  • Patients with a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis.
  • Patients with relapsing remitting multiple sclerosis and two or more relapses within the last two years.
  • Patients with secondary progressive multiple sclerosis with active disease, evidenced by relapses.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Interferon beta-1b is contraindicated in the following cases:

Severe depression, suicidal ideation

at least one of
Severe depression
Suicidal ideation

Decompensated liver disease

Hepatopathy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: EXTAVIA Powder and solvent for solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈